Dabigatran versus enoxaparin after total hip replacement.
Martins
Herlon S
HS
Scalabrini-Neto
Augusto
A
Velasco
Irineu T
IT
D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use*; D019644:Arthroplasty, Replacement, Hip; D001562:Benzimidazoles / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D000069604:Dabigatran; D017984:Enoxaparin / Q000627:therapeutic use*; D006801:Humans; D010690:Phlebography; D011183:Postoperative Complications / Q000517:prevention & control*; D011725:Pyridines / Q000627:therapeutic use*; D054556:Venous Thromboembolism / Q000000981:diagnostic imaging / Q000517:prevention & control*
D000925:Anticoagulants; D001562:Benzimidazoles; D017984:Enoxaparin; D011725:Pyridines; D000069604:Dabigatran